Search Results - "Pirillo, M F"

HIV-1 coreceptor switch during 2 years of structured treatment interruptions by Baroncelli, S., Galluzzo, C. M., Andreotti, M., Pirillo, M. F., Fragola, V., Weimer, L. E., Giuliano, M., Vella, S., Palmisano, L.

“…The purpose of this investigation was to determine the impact on human immunodeficiency virus (HIV) tropism of uncontrolled virus exposure during 2 years of…”
Get full text

Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women by Villani, P., Floridia, M., Pirillo, M. F., Cusato, M., Tamburrini, E., Cavaliere, A. F., Guaraldi, G., Vanzini, C., Molinari, A., Antoni, A. degli, Regazzi, M.

“…Aims To compare steady‐state nelfinavir (NFV) pharmacokinetics in pregnant and nonpregnant HIV‐infected women. Methods Twenty‐five pregnant HIV‐infected women…”
Get full text

Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors by Bucciardini, R, D'Ettorre, G, Baroncelli, S, Ceccarelli, G, Parruti, G, Weimer, L E, Fragola, V, Galluzzo, C M, Pirillo, M F, Lucattini, S, Bellagamba, R, Francisci, D, Ladisa, N, Degli Antoni, A, Guaraldi, G, Manconi, P E, Vullo, V, Preziosi, R, Cirioni, O, Verucchi, G, Floridia, M

“…We evaluated rates and determinants of virological failure in triple-class experienced patients receiving raltegravir-based regimens from a national…”
Get more information

A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation by Cirioni, O, Weimer, L E, Fragola, V, Giacometti, A, Ancarani, F, Maracci, M, Gabrielli, E, Marchionni, E, Pirillo, M F, Vella, S

“…In this case report, we examine the impact of a simplified two-drug highly active antiretroviral therapy (HAART) regimen of raltegravir and lamivudine in a…”
Get full text

The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy by Palmisano, L, Giuliano, M, Galluzzo, CM, Amici, R, Andreotti, M, Weimer, LE, Pirillo, MF, Fragola, V, Bucciardini, R, Vella, S

“…Objectives The aim of the study was to determine the modifications of the mutational archive in proviral HIV‐1 DNA occurring during 24 months of intermittent…”
Get full text

Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy by Giuliano, M., Pirillo, M.F., Liotta, G., Andreotti, M., Floridia, M., Ciccacci, F., Jere, H., Sagno, J.-B., Amici, R., Mancinelli, S., Marazzi, M.C., Vella, S., Palombi, L.

Get full text

HCV–HIV coinfected pregnant women: data from a multicentre study in Italy by Baroncelli, S., Pirillo, M. F., Amici, R., Tamburrini, E., Genovese, O., Ravizza, M., Maccabruni, A., Masuelli, G., Guaraldi, G., Liuzzi, G., Pinnetti, C., Giacomet, V., Degli Antoni, A., Vimercati, A., Dalzero, S., Sacchi, V., Floridia, Marco

“…Purpose To provide information about main pregnancy outcomes in HIV–HCV coinfected women and about the possible interactions between HIV and HCV in this…”
Get full text

Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding by Pirillo, M. F., Scarcella, P., Andreotti, M., Jere, H., Buonomo, E., Sagno, J.-B., Amici, R., Mancini, M. G., Leone, P., Ceffa, S., Mancinelli, S., Marazzi, M. C., Vella, S., Palombi, L., Giuliano, M.

“…Summary The study included 309 HIV‐infected pregnant women receiving a lamivudine‐containing antiretroviral regimen from week 25 of gestational age until…”
Get full text

Hodgkin’s disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor by Gastaldi, R., Martino, P., Gentile, G., Picardi, V., De Propris, M. S., Pirillo, M. F., De Vellis, A., Mandelli, F.

Get full text

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment by Vella, Stefano, Galluzzo, M.C, Giannini, G, Pirillo, M.F, Andreotti, M, Tomino, C, Fragola, V, Bucciardini, R, Ricciardulli, D, Binelli, A, Weimer, L.E, Floridia, M

“…Some studies on untreated patients have shown a general correlation between plasma HIV copy number and plasma infectivity in in vitro models. Recent…”
Get full text

High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin’s lymphoma with or without antiretroviral therapy during antineoplastic agents by Gastaldi, R., Martino, P., Gentile, G., De Propris, M. S., Pirillo, M. F., De Vellis, A., Mandelli, F.

Get full text

HIV‐related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/µL): an analysis of 338 clinical events from a randomized clinical trial by Floridia, M, Fragola, V, Galluzzo, CM, Giannini, G, Pirillo, MF, Andreotti, M, Tomino, C, Vella for the ISS‐IP1 Study Group, S

“…Background AIDS defining events occur infrequently in the presence of CD4 counts above 200 cells/µL. It is, however, uncertain for most of the AIDS defining…”
Get full text

A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection by Floridia, M, Tomino, C, Bucciardini, R, Ricciardulli, D, Fragola, V, Pirillo, M F, Amici, R, Giannini, G, Galluzzo, C M, Andreotti, M, Seeber, A C, Ammassari, A, Cingolani, A, Lazzarin, A, Scalise, G, Cargnel, A, Suter, F, Milazzo, F, Pastore, G, Moroni, M, Ciammarughi, R, Pini, R, Carosi, G, D'Amato, C, Contu, L, Concia, E, Bonazzi, L, Aiuti, F, Vigevani, G, Vella, S

“…ISS-IP1, a multicenter, randomized, 48-week open trial, was designed to compare the introduction of ritonavir or indinavir in patients with previous nucleoside…”
Get more information

Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4 + lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity by Vella, Stefano, Galluzzo, Clementina, Giannini, Giacomo, Pirillo, Maria F., Duncan, Ian, Jacobsen, Helmut, Andreoni, Massimo, Sarmati, Loredana, Ercoli, Lucia

Get full text

Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy by Andreoni, M, Sarmati, L, Ercoli, L, Nicastri, E, Giannini, G, Galluzzo, C, Pirillo, M F, Vella, S

“…We evaluated the degree of correlation between the variation of different HIV-1 viral load measures in response to antiretroviral therapy. A quantitative…”
Get more information

Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml : the impact of highly active antiretroviral therapy by PALMISANO, Lucia, GIULIANO, Marina, NICASTRI, Emanuele, PIRILLO, Maria Franca, ANDREOTTI, Mauro, GALLUZZO, Clementina M, BUCCIARDINI, Raffaella, FRAGOLA, Vincenzo, ANDREONI, Massimo, VELLA, Stefano

“…To determine factors associated with < 2.5 copies/ml plasma HIV RNA in subjects treated with highly active antiretroviral therapy (HAART) and with viraemia <…”
Get full text

Long-Term Evaluation of Cellular Immunity during Antiretroviral Therapy and Immunization with Human Immunodeficiency Virus Type 1 (HIV-1) Env Glycoprotein in HIV-1-Infected Persons by Carlesimo, Maurizio, Pontesilli, Oscar, Guerra, Emma C., Varani, Anna R., Bernardi, M. Livia, Ricci, Giovanni, Alario, Cecilia, Pirillo, Maria F., Mattiacci, Graziella, Leone, Patrizia, Cassone, Antonio, Aiuti, Fernando

“…Cellular immune responses to human immunodeficiency virus type 1 (HIV-1) antigens, microbial recall antigens, and CD3 monoclonal antibody were studied in…”
Get full text

Prevalence and Characteristics of Multinucleoside-Resistant Human Immunodeficiency Virus Type 1 among European Patients Receiving Combinations of Nucleoside Analogues by VAN VAERENBERGH, K, VAN LAETHEM, K, PERRIN, L, PIRILLO, M. F, RUIZ, L, SCHMIT, J.-C, SCHNEIDER, F, SCHOOLMEESTER, A, SCHUURMAN, R, STELLBRINK, H. J, STUYVER, L, VAN LUNZEN, J, ALBERT, J, VAN REMOORTEL, B, VAN WIJNGAERDEN, E, VELLA, S, WITVROUW, M, YERLY, S, DE CLERCQ, E, DESMYTER, J, VANDAMME, A.-M, BOUCHER, C. A. B, CLOTET, B, FLORIDIA, M, GERSTOFT, J, HEJDEMAN, B, NIELSEN, C, PANNECOUQUE, C

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease by FLORIDIA, M, BUCCIARDINI, R, CARGNEL, A, ALBERICI, F, DE RIENZO, B, LEONCINI, F, FIACCADORI, F, FRANCISCI, D, GRILLONE, W, ORTONA, L, PIAZZA, M, SCALZINI, A, RICCIARDULLI, D, NIGRA, E, TUMIETTO, F, VELLA, S, FRAGOLA, V, PIRILLO, M. F, WEIMER, L. E, TOMINO, C, GIANNINI, G, GALLUZZO, C. M, ANDREOTTI, M

“…The immunologic and virologic activity of nevirapine in combination with two nucleosides (zidovudine [ZDV] and didanosine [ddI]) was evaluated in…”
Get full text

Quality of life outcomes of combination zidovudine-didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients by BUCCIARDINI, Raffaella, WU, Albert W, GIANNINI, Giacomo, GALLUZZO, Clementina M, ANDREOTTI, Mauro, MASSELLA, Maurizio, VELLA, Stefano, STUDY, FLORIDIA, Marco, FRAGOLA, Vincenzo, RICCIARDULLI, Daniela, TOMINO, Carlo, WEIMER, Liliana E, PIRILLO, Maria F, MIRRA, Marco, MARZI, Massimo

“…To evaluate the quality of life outcomes in antiretroviral-naive patients randomized to zidovudine plus didanosine versus zidovudine plus didanosine plus…”
Get full text